{"date":"2026-07-14","count":12,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4745-2026-07-14-2313-12u1gr","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-07-14","time":"23:13:08","subject":"代子公司合富中國公告2026年半年度業績預告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-07-14 23:13，「代子公司合富中國公告2026年半年度業績預告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2026-07-14-1829-1qmt7r4","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2026-07-14","time":"18:29:30","subject":"公告本公司董事會決議通過發行115年度第二次員工認股權憑證","clause":"第9款","fact_date":"2026-07-14","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2026-07-14 18:29，「公告本公司董事會決議通過發行115年度第二次員工認股權憑證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-07-14-1755-1v85z60","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-07-14","time":"17:55:56","subject":"公告本公司收到臺灣證券交易所股份有限公司通知減少資本申報案停止申報生效。","clause":"第51款","fact_date":"2026-07-14","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-07-14 17:55，「公告本公司收到臺灣證券交易所股份有限公司通知減少資本申報案停止申報生效。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4160-2026-07-14-1645-3iebii","company_id":"4160","company":"訊聯基因","market":"上櫃","industry":"生技醫療","date":"2026-07-14","time":"16:45:48","subject":"公告本公司受邀參加櫃買中心與富邦證券合作之亞洲生技大展「法人說明會」","clause":"第12款","fact_date":"2026-07-16","cite_as":"公開資訊觀測站重大訊息：訊聯基因（4160），2026-07-14 16:45，「公告本公司受邀參加櫃買中心與富邦證券合作之亞洲生技大展「法人說明會」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-07-14-1637-jgdcil","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-07-14","time":"16:37:44","subject":"公告本公司股票面額變更為新台幣0.5元之變更登記已取得經濟部核准","clause":"第36款","fact_date":"2026-07-14","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-07-14 16:37，「公告本公司股票面額變更為新台幣0.5元之變更登記已取得經濟部核准」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-07-14-1610-1aomjka","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-07-14","time":"16:10:32","subject":"公告本公司買回庫藏股期間屆滿及執行情形","clause":"第35款","fact_date":"2026-07-14","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-07-14 16:10，「公告本公司買回庫藏股期間屆滿及執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2026-07-14-1533-1muo30n","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2026-07-14","time":"15:33:30","subject":"公告本公司辦理股票初次上櫃過額配售內容","clause":"第44款","fact_date":"2026-07-14","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2026-07-14 15:33，「公告本公司辦理股票初次上櫃過額配售內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2026-07-14-1530-8ujb8r","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2026-07-14","time":"15:30:51","subject":"公告本公司股票初次上櫃前現金增資收足股款暨現金增資基準日","clause":"第44款","fact_date":"2026-07-14","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2026-07-14 15:30，「公告本公司股票初次上櫃前現金增資收足股款暨現金增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-07-14-1404-1ee0ul5","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-07-14","time":"14:04:26","subject":"董事會決議召開115年第二次股東常會相關事宜(原議案文字誤植更正)","clause":"第53款","fact_date":"2026-07-03","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-07-14 14:04，「董事會決議召開115年第二次股東常會相關事宜(原議案文字誤植更正)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4106-2026-07-14-1355-18yy1jo","company_id":"4106","company":"雃博","market":"上市","industry":"生技醫療","date":"2026-07-14","time":"13:55:33","subject":"公告本公司董事長決定除息基準日等相關事宜","clause":"第14款","fact_date":"2026-07-14","cite_as":"公開資訊觀測站重大訊息：雃博（4106），2026-07-14 13:55，「公告本公司董事長決定除息基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-07-14-1119-1fqkmsr","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-07-14","time":"11:19:09","subject":"澄清媒體報導","clause":"第51款","fact_date":"2026-07-14","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-07-14 11:19，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2026-07-14-1101-1mylold","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2026-07-14","time":"11:01:12","subject":"針對115年7月14日工商時報報導「葡萄王 全年營收戰百億」澄清說明","clause":"第51款","fact_date":"2026-07-14","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2026-07-14 11:01，「針對115年7月14日工商時報報導「葡萄王 全年營收戰百億」澄清說明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}